Mycoplasma Testing Market Size, Share & Trends Report

Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kits & Reagents), By Technology (PCR, ELISA, Direct Assay, Microbial Culture), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-897-8
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the mycoplasma testing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for mycoplasma testing market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of mycoplasma testing market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Mycoplasma Testing Market Categorization:

The mycoplasma testing market was categorized into five segments, namely product (Instruments, Kits & Reagents, Services), technology (PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques, Enzymatic Methods), application (Cell Line Testing, Virus Testing, End of Production Cells Testing), end-use (Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The mycoplasma testing market was segmented into product, technology, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The mycoplasma testing market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-five countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; Russia; China; Japan; India; South Korea; Australia; Singapore; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia, UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Mycoplasma testing market companies & financials:

The mycoplasma testing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Thermo Fisher Scientific, Inc.: The company is a developer and supplier of analytical equipment, instruments, consumables, reagents, software, and services for various applications, including diagnostics, research, manufacturing, & drug discovery. The company operates across four business segments: Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services. Through the Life Sciences Solutions segment, it provides reagents, consumables, and instruments used in drug discovery as well as biological & medical research. Through the Analytical Instruments segment, it provides consumables, instruments, software, and services used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment offers diagnostic reagents, test kits, instruments, culture media, and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, & food safety laboratories.

  • Merck KGaA: The company provides a wide range of pharmaceutical and chemical products catering to various industries. This company operates through three business sectors, i.e., healthcare, life science, and performance materials. The company offers life sciences products and services for drug discovery and development along with research and laboratory applications. It also provides prescription medicines for the treatment of multiple sclerosis, colorectal cancer, diabetes, cardiovascular diseases, infertility, and others. The company also provides over-the-counter medicines, probiotic supplements, and various other products for women’s health and nutrition. In the U.S. and Canada, the company operates its life science business as MilliporeSigma, its biopharmaceutical business as EMD Serono, and its materials as EMD Performance Materials.

  • Lonza: The company caters to pharmaceutical, consumer health, biotech, and specialty ingredients industries. Lonza develops and manufactures preventive & curative medicines, nutritional ingredients, and personal care products. The company operates through two business segments—Pharma & Biotech and Specialty Ingredients. The Pharma & Biotech segment includes the chemical and biologics division along with bioscience solutions and capsule delivery solutions business units. The specialty ingredients segment includes divisions such as consumer health, consumer & resources protection, and also water care business unit. The company supplies its products to more than 30 countries across the globe and has approximately 53 manufacturing and R&D facilities.

  • Charles River Laboratories International, Inc.: The company is engaged in research animal diagnostic testing services, production & sale of research models & services, and genetically engineered models & services to the drug development industry. The company provides basic drug discovery, research, clinical development, preclinical testing, commercialization, and manufacturing services. Charles River Laboratories International, Inc. majorly focuses on infectious diseases, cardiovascular diseases, immunology, inflammation, microbiome research, metabolic diseases, musculoskeletal diseases, oncology, rare diseases, and respiratory disease areas. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The company serves pharmaceutical and biotechnology companies, academic, medical device, nutraceutical, personal care, cosmetics, and veterinary medicine industries.

  • PromoCell GmbH: The company offers a wide range of stem cells, human primary cells, and blood cells along with other optimized products for cancer cell culture that include kits used in 3D cell culture. The company supports research by offering products such as cell media, cells, and kits of excellent quality. PromoKine cell biology products help in in-depth understanding and analysis of cells in culture. This segment provides quality reagents and kits used for cell biology such as ELISAs, antibodies, growth factors, and cytokines. Along with a wide range of products the company offers training sessions to help its customers know their products better which will further enhance their practical skills. PromoCell Gmbh established PromoCell Academy in 2004 to provide insights into life sciences. Currently, the company offers more than 7,000 products.

  • American Type Culture Collection (ATCC): supplies advanced cell models and authenticated cells. American Type Culture Collection provides services to support scientific research as well as breakthroughs to improve the health of the global population. It serves the biotechnology, pharmaceutical, diagnostics, and agricultural industries majorly. The company also serves cosmetic makers, testing laboratories, and food & beverage industries. American Type Culture Collection offers its products through a wide range of distributors globally.

  • Bionique Testing Laboratories, Inc.: The company provides mycoplasma testing products as well as services that help clients meet individual quality standards. The company provides mycoplasma testing services through Bionique Testing Laboratories, Inc. It offers excellence in quality mycoplasma services and also in products, they meet the customer demands for mycoplasma testing, regulatory compliance, & quality assurance, the company also uses advanced & emerging technologies for research and mycoplasma detection. The company ensures the highest standards of quality control and quality assurance activities and strict confidentiality of samples and results.

  • Biological Industries Israel Beit Haemek Ltd.: a subsidiary of Sartorius AG develops and markets cytogenetic products that include media for culturing chorionic villi cells and amniotic fluid. The company offers serum-free reagents and media that improve the control of cell culture conditions. It offers a range of reagents to support various researchers in reprogramming, culturing, characterizing, and differentiating colonies consisting of stem cells and reagents for cytogenetic analysis. In addition, the company also offers reagents used in the treatment and detection of mycoplasma and lab disinfection, components as well as kits for isolation of nucleic acid, and purification of samples such as protein detection & cDNA amplification. Biological Industries Israel Beit Haemek Ltd. collaborates with the industry’s leading biotechnology companies and academic institutes.

  • Invivogen: The company is a provider of science research products. The company’s strength lies in innovation that comes from its expert scientific team that fosters the design and discovery of new services and tools that help encourage cutting-edge biotech research. The company has expertise in the fermentation of microbes which enables the company to provide a varied range of biological molecules that include mycoplasma treatments, antibiotics, and receptor agonists that are derived from micro-organisms. The company consists of strong biology and chemistry teams that focus their studies on the synthesis of molecules as well as plasmids that are used for research and studies that are mostly focused on vaccination and gene therapy.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Mycoplasma Testing Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Mycoplasma Testing Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon